Jasper Therapeutics Highlights Recent Accomplishments and Key Upcoming Milestones
- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively
Stay updated with breaking news from Herb Cross. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively
- EU Clinical Trials authorized for Phase 1b/2a SPOTLIGHT and BEACON studies of briquilimab in CIndU and CSU, respectively - Patient enrollment in Phase...
(RTTNews) - Biotechnology company Jasper Therapeutics, Inc. (JSPR) announced Monday the appointment of Herb Cross, an experienced senior financial...
“I knew more than anyone else about insurance risks,” Rowan recalls of his first foray into the industry. His understanding of the market led him to marry the firm he founded to a profitable insurer.
SAN CARLOS, Calif., Sept. 21, 2023 -- Atreca, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on...